Thomas Joseph Logan

Title: Thomas Joseph Logan: Innovator in Acyltransferase Research

Introduction

Thomas Joseph Logan is a notable inventor based in Springfield, PA (US). He has made significant contributions to the field of biochemistry, particularly in the study of acyltransferases. With a total of 5 patents to his name, Logan's work has advanced our understanding of these important enzymes.

Latest Patents

One of Logan's latest patents is titled "ACTR-1, a novel human acyltransferase and uses thereof." This invention provides isolated nucleic acid molecules, designated ACTR-1 nucleic acid molecules, which encode novel acyltransferase family members. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing ACTR-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an ACTR-1 gene has been introduced or disrupted. Furthermore, the invention provides isolated ACTR-1 proteins, fusion proteins, antigenic peptides, and anti-ACTR-1 antibodies. Diagnostic methods utilizing compositions of the invention are also included.

Career Highlights

Throughout his career, Logan has worked with prominent companies in the pharmaceutical and healthcare sectors. Notable organizations include Millennium Pharmaceuticals Limited and Bayer Healthcare Aktiengesellschaft. His experience in these companies has allowed him to collaborate on various innovative projects.

Collaborations

Logan has worked alongside talented individuals such as Rosana Kapeller-Libermann and Maria Alexandra Glucksmann. These collaborations have contributed to the success of his research and patent applications.

Conclusion

Thomas Joseph Logan is a distinguished inventor whose work in acyltransferase research has led to significant advancements in the field. His contributions continue to impact biochemistry and related disciplines.